Nanoparticle delivery through the BBB in central nervous system tuberculosis.

Anna Griego1,2, Edoardo Scarpa1,2, Valeria De Matteis3

  • 1Department of Pharmaceutical Sciences University of Milan Milan Italy.

Ibrain
|October 3, 2023
PubMed
Summary

This review details nanoparticle (NP) interactions within the brain, focusing on the blood-brain barrier (BBB). It offers guidelines for designing effective NPs for treating brain infections like central nervous system tuberculosis (CNS-TB).